Basic & Clinical Medicine ›› 2022, Vol. 42 ›› Issue (5): 788-794.doi: 10.16352/j.issn.1001-6325.2022.05.021
• Original Articles • Previous Articles Next Articles
HU Shi-qi1, LAN Yan-qi1, WU Shou-ling2, WANG Xiao-mo1, CHEN Shuo-hua2, WANG Guo-dong2*, WANG Li1*
|  Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases[J]. Hepatology, 2018,67:328-357.
Younossi Z, Anstee QM, Marietti M, et al. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention[J]. Nat Rev Gastro Hepat, 2018,15:11-20.
Younossi ZM, Koenig AB, Abdelatif D, et al. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes[J]. Hepatology, 2016,64:73-84.
Targher G, Marra F, Marchesini G. Increased risk of cardiovascular disease in non-alcoholic fatty liver disease: causal effect or epiphenomenon?[J]. Diabetologia, 2008,51:1947-1953.
Targher G, Day CP, Bonora E. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease[J]. New Engl J Med, 2010,363:1341-1350.
Younossi ZM, Corey KE, Lim JK. AGA clinical practice update on lifestyle modification using diet and exercise to achieve weight loss in the management of nonalcoholic fatty liver disease: expert review[J]. Gastroenterology, 2021,160:912-918.
Wang F, Wu S, Song Y, et al. Waist circumference, body mass index and waist to hip ratio for prediction of the metabolic syndrome in Chinese[J]. Nutr Metab Cardiovas, 2009,19:542-547.
World Health Organization. Waist circumference and waist-hip ratio report of a WHO expert consultation[EB/OL]. https://apps.who.int/iris/handle/10665/44583, (2008-12-31)
WHO expert consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies[J]. Lancet, 2004,363:157-163.
 Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk[J]. J Am Stat Assoc, 1999,94:496-509.
 Friedman SL, Neuschwander-Tetri BA, Rinella M, et al. Mechanisms of NAFLD development and therapeutic strategies[J]. Nat Med, 2018,24:908-922.
 Sookoian S, Pirola CJ. Non-alcoholic fatty liver disease is strongly associated with carotid atherosclerosis: a syste-matic review[J]. J Hepatol, 2008,49:600-607.
 Wang AY, Dhaliwal J, Mouzaki M. Lean non-alcoholic fatty liver disease[J]. Clin Nutr, 2019,38:975-981.
 Pang Q. Central obesity and nonalcoholic fatty liver disease risk after adjusting for body mass index[J]. World J Gastroentero, 2015,21:1650-1651.
 Dasarathy S, Dasarathy J, Khiyami A, et al. Validity of real time ultrasound in the diagnosis of hepatic steatosis: a prospective study[J]. J Hepatol, 2009,51:1061-1067.
|||LIU Yan-li, ZHAO Rui-xue, PAN Yan, MA Ya-jun, ZHAO Tun, JIANG Xiao-yan, LI Shu-juan. Depressive symptoms increase the risk of falls in elderly Chinese [J]. Basic & Clinical Medicine, 2022, 42(6): 945-949.|
|||SHI Dong-xue, YUAN Jia-qi, DING Bao-feng, WAGN Xiao-shuang, YU Jia. Liver pathological changes and hepatocyte acquisition method of model mice with non-alcoholic fatty liver disease [J]. Basic & Clinical Medicine, 2022, 42(6): 890-895.|
|||. Research progress on the role of TRIB3 in obesity pathogenesis [J]. Basic & Clinical Medicine, 2021, 41(9): 1352-1355.|
|||. Probiotics improve lipid metabolism of obese mice induced by high-fat and high-sucrose diet [J]. Basic & Clinical Medicine, 2021, 41(9): 1260-1265.|
|||. Motoric cognitive risk syndrome increases the risk of hospitalization in the elderly [J]. Basic & Clinical Medicine, 2021, 41(8): 1169-1173.|
|||. Research progress of inflammatory response of adipose tissue [J]. Basic & Clinical Medicine, 2021, 41(7): 1052-1055.|
|||XU Ke, HU Xiang, YU Wei-hui, YANG Li-juan, GU Xue-jiang. Relationship between metabolically healthy obesity and the prevalence of non-alcoholic fatty liver disease [J]. Basic & Clinical Medicine, 2021, 41(6): 837-841.|
|||HUANG Xian, WU Shou-ling, CHEN Shuo-hua, SUN Yuan-yuan, ZHANG Di, GUO Shu-xia, WANG Li. A cohort-based case control study on the association between the whole blood iron and copper with cardiovascular diseases [J]. Basic & Clinical Medicine, 2021, 41(5): 709-714.|
|||SHI Ying, GUO Yong-fang, DENG Yu-ting, DAI Hong-yan, GUAN Jun. Research progress on the role of Salusin-β in cardiovascular diseases [J]. Basic & Clinical Medicine, 2021, 41(2): 282-286.|
|||. Enhanced recovery after surgery promotes postoperative recovery of patients receiving robot assisted laparoscopic insulinoma enucleation [J]. Basic & Clinical Medicine, 2020, 40(4): 543-546.|
|||. Advances in research on the relationship between intestinal flora and diseases [J]. Basic & Clinical Medicine, 2020, 40(2): 243-247.|
|||ZHU Kun, DAI Ri-lei, ZHU Wen-ting, LI Zhen-yan, CAO Chun-mei. Progress in research on pyroptosis and cardiovascular diseases [J]. Basic & Clinical Medicine, 2020, 40(12): 1711-1715.|
|||. Preparation of antibody against mouse UPF1 and the expression of UPF1 in adipose cell differentiation [J]. Basic & Clinical Medicine, 2018, 38(3): 335-339.|
|||. Progress in mechanism of IKKε promoting the development of metabolic diseases [J]. Basic & Clinical Medicine, 2015, 35(12): 1686-1690.|
|||. Inhibitory effect of telmisartan on non-alcoholic fatty liver fibrosis in rats [J]. Basic & Clinical Medicine, 2014, 34(10): 1321-1326.|